The Precision Peptide Genetic Test ($99 add-on or $298 standalone) examines your genetic variants in GLP1R, GIPR, FTO, and MC4R pathwaysmarkers associated with baseline GLP-1 sensitivity, appetite-satiety signaling, and fat mass genetics
Be direct with your question: "Hello, I am currently taking Tirzepatide under a doctor's supervision for weight loss
Boehringer Ingelheim today announced positive topline results from the Phase III SYNCHRONIZE-1 trial, in which survodutide (BI 456906) met the co-primary endpoints using both the efficacy and treatment-regimen estimands
It touches systems that also respond to estrogen, progesterone, cortisol, and thyroid hormones
Phase 3 trials are underway, and a realistic approval window is late 2026 at the earliest, more likely 2027